Overview
| Candidate | Pre | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|
PRO 140 |
Pre-Clinical Phase completed
|
Phase 1 completed
|
Phase 2 completed
|
Phase 3 in progress
|
CytoFeline |
Pre-Clinical Phase completed
|
Phase 1 completed
|
Phase 2 in progress
|
Phase 3 not started
|
Cytolin |
Pre-Clinical Phase in progress
|
PRO 140
PRO 140 is a fully humanized monoclonal antibody which is a cellular targeting CCR5 entry antagonist recently acquired from Progenics Pharmaceuticals.
CytoFeline
This virus is a member of the Lentivirus subfamily of Retroviruses.
Read more about CytoFeline ...
Cytolin®
Cytolin® is a mouse monoclonal antibody that was originally developed to identify a specific type of immune cell called a cytotoxic T cell, or CTL.